| Ticker Details |
|
Revelation Biosciences, Inc.
|
| IPO Date: |
November 18, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$3.72M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 5.42%
|
| Avg Daily Range (30 D): |
$0.07 | 4.74%
|
| Avg Daily Range (90 D): |
$0.05 | 3.80%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.29M |
| Avg Daily Volume (30 D): |
1.17M |
| Avg Daily Volume (90 D): |
.42M |
| Trade Size |
| Avg Trade Size (Sh.): |
76 |
| Avg Trade Size (Sh.) (30 D): |
101 |
| Avg Trade Size (Sh.) (90 D): |
99 |
| Institutional Trades |
| Total Institutional Trades: |
3 |
| Avg Institutional Trade: |
$.84M |
| Avg Institutional Trade (30 D): |
$M |
| Avg Institutional Trade (90 D): |
$M |
| Avg Institutional Trade Volume: |
M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$256.61
|
$-1.77
|
$-7.01
|
|
Diluted EPS
|
$255.48
|
$-1.77
|
$-7.01
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-8.13M
|
$-1.91M
|
$-2.44M
|
|
Operating Income / Loss
|
$-8.25M
|
$-1.94M
|
$-2.46M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-.04M
|
$M
|
$2.79M
|
|
PE Ratio
|
0.01
|
|
|
| Splits |
|
Jan 28, 2026
|
1:4
|
|
Jul 07, 2025
|
1:3
|
|
Jan 28, 2025
|
1:16
|
|
Jan 25, 2024
|
1:30
|
|
Feb 01, 2023
|
1:35
|
|
|
|